Growing use of off-label neurological drugs for pain: Study
Business Insurance - Aug 17, 2021
Ninety-nine percent of injured workers who were prescribed a common epilepsy drug did not have a documented diagnosis for one of the approved conditions per the Food and Drug Administration, according to a study released Tuesday linking the use of such drugs as an alternative to opioids in workers c...
Recommended Articles
Posted: Aug 22, 2023
South Korean insurers’ combined net profits increased to around 8 trillion South Korean won ($5.95 b...
Posted: Aug 22, 2023
According to a new report from Aon PLC, South Africa’s insurance market is continuing to see reduced...
Posted: Aug 22, 2023
Independent insurance brokerage Latin RE is the first Brazilian broker to get a license to operate d...